AVANOS MEDICAL, INC. (AVNS)
2025-06-30 | 2025-03-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|
| Net sales | 175,000,000 | 167,500,000 | 170,400,000 | 171,700,000 |
| Cost of products sold | 82,900,000 | 77,700,000 | 77,500,000 | 76,100,000 |
| Gross profit | 92,100,000 | 89,800,000 | 92,900,000 | 95,600,000 |
| Goodwill impairment | 77,000,000 | - | - | - |
| Other (income) expense, net | -300,000 | 1,600,000 | 600,000 | -2,100,000 |
| Research and development | 5,800,000 | 5,400,000 | 7,200,000 | 6,300,000 |
| Selling and general expenses | 83,500,000 | 75,700,000 | 74,300,000 | 80,900,000 |
| Operating (loss) income | -74,500,000 | 10,300,000 | 12,000,000 | 6,300,000 |
| Interest income | 600,000 | 1,500,000 | 700,000 | 3,000,000 |
| Interest expense | 2,000,000 | 2,100,000 | 3,200,000 | 3,100,000 |
| (loss) income before income taxes | -75,900,000 | 9,700,000 | 9,500,000 | 6,200,000 |
| Income tax provision | 900,000 | 3,100,000 | 3,600,000 | 1,900,000 |
| (loss) income from continuing operations | -76,800,000 | 6,600,000 | 5,900,000 | 4,300,000 |
| Loss from discontinued operations, net of tax | - | - | -1,600,000 | -2,500,000 |
| Net (loss) income | -76,800,000 | 6,600,000 | 4,300,000 | 1,800,000 |
| Basic (loss) earnings per share (in dollars per share) | -1.66 | 0.14 | 0.1 | 0.04 |
| Basic weighted average shares outstanding (in shares) | 46,300,000 | 46,100,000 | 46,000,000 | 45,900,000 |
| Diluted (loss) earnings per share (in dollars per share) | -1.66 | 0.14 | 0.09 | 0.04 |
| Diluted weighted average shares outstanding (in shares) | 46,300,000 | 46,800,000 | 46,600,000 | 46,300,000 |